Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome.

Moreira W, Santhanakrishnan S, Dymock BW, Dick T
Front Microbiol. 2017 Apr 27;8:746. doi: 10.3389/fmicb.2017.00746. eCollection 2017. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.